Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

Published:2011-01-24 Issue:6 Volume:108 Page:2462-2467
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Takiar V.,Nishio S.,Seo-Mayer P.,King J. D.,Li H.,Zhang L.,Karihaloo A.,Hallows K. R.,Somlo S.,Caplan M. J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference46 articles.

1. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro

2. The relationship between cell proliferation, Cl− secretion, and renal cyst growth: A study using CFTR inhibitors

3. Small-Molecule CFTR Inhibitors Slow Cyst Growth in Polycystic Kidney Disease

4. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)

5. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease – A Randomized Control Trial;Indian Journal of Nephrology;2024-08-29

2. Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease;Nutrients;2024-08-06

3. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease;Biomolecules;2024-07-07

4. Reprogramming of Energy Metabolism in Human PKD1 Polycystic Kidney Disease: A Systems Biology Analysis;International Journal of Molecular Sciences;2024-06-29

5. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials;BMC Nephrology;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3